Recommendations from the EGAPP Working Group: Can Testing of Tumor Tissue for Mutations in EGFR Pathway Downstream Effector Genes in Patients with Metastatic Colorectal Cancer Improve Health Outcomes by Guiding Decisions Regarding anti-EGFR Therapy? (Feb 2013)

Calonge N, Fisher NL, Berg AO, et al. Genet Med. 2013; doi: 10.1038/gim.2012.184. PMID: 23429431.